<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - J&J Will Enroll 60,000 COVID-19 Vaccine Trial Participants
Image Overlay - J&J Will Enroll 60,000 COVID-19 Vaccine Trial Participants

J&J Will Enroll 60,000 COVID-19 Vaccine Trial Participants

J&J Will Enroll 60,000 COVID-19 Vaccine Trial Participants

Johnson & Johnson will enroll 60,000 trial participants in COVID-19 clinical trials. The company has said it will know if the vaccine is effective by the end of this year. The vaccine is differentiated from competitors because it requires only one dose instead of two and will not require freezing. The trials will take place in the United States, Argentina, Brazil, Chile, Colombia, Mexico, Peru, and South Africa. Yourway has a global presence and depots located around the world – because of our over 20 strategically located depot facilities, we get your clinical materials around the world in hours, not days.

Back to Index
Media

Upcoming Events

Precision in Pharma Supply Chain & Logistics Summit (Munich)

April 15-16, 2024
Science Congress Center Munich

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?